Loading clinical trials...

COMPLETEDPHASE4

Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen

NCT00791973•University of Chicago

Summary

The purpose of this study is to help us to a better understanding of how nose and eye symptoms are related in patients with allergies.

Eligibility

Age

18 - 45 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Males and females between 18 and 45 years of age.
•2. History of grass and/or ragweed allergic rhinitis.
•3. Positive skin test to grass and/or ragweed antigen.
•4. Positive response to screening nasal challenge.

Exclusion Criteria

•1. Physical signs or symptoms suggestive of renal, hepatic or cardiovascular disease.
•2. Pregnant or lactating women.
•3. Upper respiratory infection within 14 days of study start.

Locations (1)

University of Chicago Medical Center

Chicago, Illinois, United States

Key Dates

Start Date

November 1, 2008

Primary Completion Date

April 1, 2009

Completion Date

May 1, 2010

Last Updated

July 8, 2014

Enrollment

ACTUAL participants

Conditions

Allergic Rhinitis

Interventions

fluticasone furoate

DRUG

Placebo

DRUG

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

NCT06732414

Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a

View study

RECRUITINGNA

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

NCT05494346

Acute RhinitisNasal Obstruction+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 8, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen

Inclusion Criteria

Exclusion Criteria

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT

Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis

Tyrosine Allergoid Paediatric and Adult Study